Rabies

Zoetis Releases 2023 Sustainability Report to Share Progress in Building a Better Future for Communities, Animals and the Planet

Retrieved on: 
수요일, 6월 5, 2024

The report shares Zoetis’ actions to meet aspirations across three pillars: Communities, Animals and Planet.

Key Points: 
  • The report shares Zoetis’ actions to meet aspirations across three pillars: Communities, Animals and Planet.
  • In total, the company’s community programs reached approximately 202,000 pet owners in need and approximately 91,000 animals impacted by disaster.
  • For more detailed disclosure on the company’s sustainability programs, practices and policies, please see zoetis.com/sustainability or download Zoetis’ 2023 Sustainability Report .
  • Zoetis will continue to share updates on its sustainability activities, including progress against its Driven to Care goals, and report annually.

HOUSTON PETSET VACCINATES AND MICROCHIPS 775 CATS AND DOGS AT FREE COMMUNITY EVENT

Retrieved on: 
목요일, 6월 13, 2024

HOUSTON, June 13, 2024 /PRNewswire/ -- Houston PetSet, a local nonprofit organization working to end Houston's homeless animal crisis, returned to the Baytown Community Center to provide vaccines and microchips for owned cats and dogs at no cost to their owners. This was their third large-scale community event of 2024, bringing the total number of pets served to nearly 2,500 to date. These quarterly events have become a necessity for pet owners as the costs of veterinary care continue to climb.

Key Points: 
  • HOUSTON, June 13, 2024 /PRNewswire/ -- Houston PetSet , a local nonprofit organization working to end Houston's homeless animal crisis, returned to the Baytown Community Center to provide vaccines and microchips for owned cats and dogs at no cost to their owners.
  • This was their third large-scale community event of 2024, bringing the total number of pets served to nearly 2,500 to date.
  • Houston PetSet is only able to provide these vital veterinary services free of charge through the generosity of local donors and businesses.
  • Houston PetSet's next free community event will take place in Acres Homes on Saturday, October 12, 2024.

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Retrieved on: 
화요일, 5월 14, 2024

JUPITER, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as non-pharmaceutical applications including food, nutrition, and wellness, today announced its financial results for the first quarter of 2024 and highlighted recent Company progress.

Key Points: 
  • ET today
    JUPITER, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as non-pharmaceutical applications including food, nutrition, and wellness, today announced its financial results for the first quarter of 2024 and highlighted recent Company progress.
  • In March 2024, the Company entered into a co-promotion agreement with Biftek Co. for the promotion of growth media supplement for cell culture.
  • The Company is undergoing a beta-lactoglobulin animal-free recombinant whey protein project, expected to begin sampling in the late third quarter.
  • The Company is undergoing a recombinant lactoferrin project, expected to begin sampling the product in the late second or early third quarter.

African wild dogs will soon have their own sperm bank – how artificial breeding will help them survive

Retrieved on: 
수요일, 4월 10, 2024

They’ve now decided to freeze sperm from as many genetically diverse male African wild dogs as possible and use this to artificially inseminate female African wild dogs for the first time.

Key Points: 
  • They’ve now decided to freeze sperm from as many genetically diverse male African wild dogs as possible and use this to artificially inseminate female African wild dogs for the first time.
  • Reproductive and molecular biologist Damien Paris explains why artificial breeding is the best and most economical way to ensure that genetically diverse wild dogs live on.

Why is the African wild dog in danger?

  • They are highly efficient pack hunters but need large home ranges to survive and avoid competitors like lions.
  • The problem is that most of the remaining habitats are so small and fragmented that they can’t support large populations anymore.
  • Usually, when wild dogs are subadults (around two years old) they move far away and form their own pack.

How can genetic diversity help the African wild dog survive?

  • Those diseases can spread rapidly among wild dogs and decimate a pack, which is about five to 20 dogs.
  • In 2017, canine distemper virus completely wiped out 21 out of 22 packs of wild dogs in Laikipia County, Kenya in less than four weeks.
  • We plan to use sperm freezing and artificial insemination to help distribute genetic diversity between isolated populations.

What conservation methods have been used before?

  • To increase genetic diversity, African wild dogs have been translocated (moved) across South Africa since 1998.
  • Over several weeks, they form a new genetically mixed pack that is released into the wild.
  • A whole population of wild dogs could be lost with the next disease outbreak.

How will sperm freezing and artificial insemination help?

  • Our back-up plan against disease outbreaks is to create a bank of African wild dog sperm from multiple males.
  • Sperm frozen in liquid nitrogen tanks at very cold temperatures can last 50 or 100 years and still produce offspring.
  • We recently improved the freezing technique so African wild dog sperm are now able to swim and survive for eight hours after being thawed.
  • We plan to build a consortium so that we can have multiple sperm banks throughout South Africa as back-ups.

Will this be very expensive?

  • Some recent modelling in other species found that the hybrid approach was between seven and 84 times cheaper than the natural breeding approach.
  • This is because it needed 13-100 times fewer animals to maintain 90% genetic diversity in the population over a 100-year period.


Damien Boyd Bertrand Paul Paris receives funding from Morris Animal Foundation, Roger Willliams Park
Zoo and Fresno Chaffee Zoo. He is affiliated with James Cook University, the Institute for Breeding Rare and Endangered African Mammals, and is a Visiting Fellow of the Mammal Research Institute.

Dyadic Reports 2023 Full Year Results and Recent Company Progress

Retrieved on: 
목요일, 3월 28, 2024

“In 2023, Dyadic achieved significant milestones in unlocking the potential of its microbial platforms.

Key Points: 
  • “In 2023, Dyadic achieved significant milestones in unlocking the potential of its microbial platforms.
  • We believe that we are well-positioned, both financially and scientifically, to execute our strategic plan with enhanced capabilities and resources.
  • For the year ended December 31, 2023, the Company received a total of approximately $1.3 million in connection with the sale of Alphazyme LLC.
  • Other Income: For the year ended December 31, 2023, the Company had a gain of approximately $1,018,000 from the sale of the Company’s equity interest in Alphazyme, LLC.

Sanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groups

Retrieved on: 
금요일, 4월 5, 2024

Sanofi (EURONEXT: SAN and NASDAQ: SNY) has today announced the launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK, an inactivated rabies vaccine indicated for pre-exposure and post-exposure prophylaxis of rabies in all age groups.1

Key Points: 
  • Sanofi (EURONEXT: SAN and NASDAQ: SNY) has today announced the launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK, an inactivated rabies vaccine indicated for pre-exposure and post-exposure prophylaxis of rabies in all age groups.1
    This launch is based on extensive clinical data from over 13,000 individuals.1 Sanofi Inactivated Rabies Vaccine has been approved and widely used in more than 80 countries.2 It is estimated that between 41 and 70 million individuals have received the vaccine since its first licensure in May 1985, in France.2
    Rabies is nearly always fatal once symptoms appear, but can be preventable with vaccination3
    Each year, an estimated 59,000 people worldwide die from rabies.4 That’s one person every nine minutes of every day3, with approximately 95% of deaths occurring in Asia and Africa.3,4,5 Individuals travelling to these countries should be aware of the risk of rabies and take the appropriate precautionary measures.
  • Rebecca Catterick, UK and Ireland Sanofi Vaccines General Manager, said:
    “Rabies is a fatal, travel-related vaccine-preventable disease.
  • The availability of Verorab® in the UK provides an effective immunisation option for those travelling to high-risk countries, as well as a treatment for post-rabies exposure.”
    Joanna Lowry, Specialist Travel Nurse & Educator, said:
    “I am always surprised by the number of British travellers I meet who are unaware of the risk of rabies.
  • Increasing awareness and sharing education on preventative measures is crucial to help reduce the possibility of this devastating disease.”
    Rabies is primarily transmitted by the bite, scratch, or lick of a rabid animal, 99% of which are by dogs, but can also be other wildlife, such as foxes or bats.6

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

Retrieved on: 
수요일, 2월 28, 2024

The aim is to develop highly efficacious, scalable, and affordable rabies prophylactics and vaccines utilizing Dyadic's C1 protein production platform.

Key Points: 
  • The aim is to develop highly efficacious, scalable, and affordable rabies prophylactics and vaccines utilizing Dyadic's C1 protein production platform.
  • This collaboration seeks to address the global burden of rabies, a disease that annually claims tens of thousands of lives.
  • As per the strategic partnership agreement, Dyadic will receive an equity stake in, fully funded research and development costs, and specified product milestones and royalties upon commercialization.
  • Punt highlighted the potential of combining advances in vaccinology with Dyadic's C1 protein production platform to accelerate research, enhance product development, and lower manufacturing costs.

Oakland Zoo Provides Care for Recently Seized Marmoset Monkey

Retrieved on: 
목요일, 2월 8, 2024

OAKLAND, Calif., Feb. 8, 2024 /PRNewswire-PRWeb/ -- On January 20th, Oakland Zoo worked with the California Department of Fish and Wildlife (CDFW) and the Wildlife Confiscation Network (WCN) to rescue an illegally owned female marmoset in a seizure of the monkey from a private residence in southern California. The owner was arrested on other charges unrelated to having the female marmoset and was made aware in advance that the animal was to be seized by authorities. Oakland Zoo was contacted after San Diego Zoo and Los Angeles Zoo (other Association of Zoos and Aquariums accredited partners) could not take in the marmoset due to the capacity concerns related to other WCN rescues they were involved with.

Key Points: 
  • Oakland Zoo is caring for a female marmoset named Estrela, an illegally owned pet, after being seized by California Department of Fish and Wildlife officials.
  • Oakland Zoo was contacted after San Diego Zoo and Los Angeles Zoo (other Association of Zoos and Aquariums accredited partners) could not take in the marmoset due to the capacity concerns related to other WCN rescues they were involved with.
  • Estrela will remain in the care of the Oakland Zoo and housed in their Veterinary Hospital until she has completed her quarantine period.
  • For years, animals confiscated by officials at SFO, and the Port of Oakland have been brought to Oakland Zoo for treatment, care, and permanent sanctuary.

Alley Cat Rescue's 2023 Global Feral Fix Challenge Results in Record Number of Community Cat Spays/Neuters

Retrieved on: 
수요일, 1월 31, 2024

MOUNT RAINIER, Md., Jan. 31, 2024 /PRNewswire-PRWeb/ -- The 13th cycle of Alley Cat Rescue's annual Feral Fix Challenge ran from March 15 through December 31, 2023, with record results. The Challenge is a global event that invites veterinarians to get involved with trap-neuter-return (TNR) by providing low-cost or free spay/neuter surgeries and rabies vaccinations for free-roaming cats. The goal of the Challenge is to save feral cats from shelter euthanasia, starvation, and disease by humane population management.

Key Points: 
  • MOUNT RAINIER, Md., Jan. 31, 2024 /PRNewswire-PRWeb/ -- The 13th cycle of Alley Cat Rescue's annual Feral Fix Challenge ran from March 15 through December 31, 2023, with record results.
  • The Challenge is a global event that invites veterinarians to get involved with trap-neuter-return (TNR) by providing low-cost or free spay/neuter surgeries and rabies vaccinations for free-roaming cats.
  • The goal of the Challenge is to save feral cats from shelter euthanasia, starvation, and disease by humane population management.
  • Alley Cat Rescue is a national nonprofit organization dedicated to the welfare of all cats: domestic, stray, abandoned, and feral.

Global Market for Animal Therapeutics and Diagnostics Poised to Reach $81.2 Billion by 2028 - BCC Research Analyst

Retrieved on: 
목요일, 1월 25, 2024

BOSTON, Jan. 25, 2024 /PRNewswire/ -- The Global Markets for Animal Therapeutics and Diagnostics are undergoing a transformative phase, driven by a surge in awareness and investment in animal health. This dynamic market encompasses a broad spectrum of therapeutic interventions and diagnostic solutions designed to enhance the well-being of animals worldwide. As the demand for advanced healthcare for companion and livestock animals intensifies, the global market is poised to reach $81.2 billion by 2028. This introduction explores the trends, innovations, and market dynamics propelling the growth of animal therapeutics and diagnostics on a global scale. From breakthrough treatments to cutting-edge diagnostic technologies, this market is evolving to meet the increasing expectations for animal welfare and healthcare standards.

Key Points: 
  • With a Steady 5.9% CAGR, the Market for Animal Therapeutics and Diagnostics is Set to Expand from $61.0 Billion in 2023 to$81.2 Billion by 2028.
  • As the demand for advanced healthcare for companion and livestock animals intensifies, the global market is poised to reach $81.2 billion by 2028.
  • This introduction explores the trends, innovations, and market dynamics propelling the growth of animal therapeutics and diagnostics on a global scale.
  • This comprehensive report offers an extensive overview of the global animal therapeutics and diagnostics market, leveraging 2022 as the base year and forecasting the compound annual growth rate (CAGR) from 2023 to 2028.